55 reports

  • MARKET SIZE AND FORECAST

Genetic and co-morbid influences also play major roles in the increasing incidences of PVDs.

  • Cardiovascular Devices
  • Interventional Cardiology Device
  • Boston Scientific Corporation
  • Cordis Corporation
  • Medtronic, Inc.

You can easily book an appointment with one online.

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Opsens Inc.

A cerebral aneurysm occurs due to hypertension, smoking, injury or trauma to blood vessels, and genetic predisposition.

  • Cardiovascular Devices
  • Abbott Laboratories, Inc.
  • Medtronic, Inc.
  • Stryker Corporation
  • Terumo Corporation

BRUGADA SYNDROME IS A GENETIC DISEASE THAT PREDISPOSES TO HEART ATTACK OR SUDDEN DEATH DUE TO MALIGNANT VENTRICULAR TACHYARRHYTHMIA.

  • Cardiovascular Devices
  • Southern Europe
  • Spain
  • Market Size
  • Boston Scientific Corporation

GENETIC MAKEUP ALSO PLAYS A MAJOR PART IN THE DEVELOPMENT OF AORTIC ANEURYSMS.

  • Cardiovascular Devices
  • World
  • Market Size
  • Endologix, Inc.
  • Medtronic, Inc.

ONE UNIT REFERS TO ONE PAL SYSTEM.

  • Cardiovascular Devices
  • East Asia
  • Japan
  • Forecast
  • Olympus Corporation
  • Interventional Cardiology Device Market: Revenue in USD billion, Japan, 2015-2023
  • Interventional Cardiology Device Market: Revenue in USD billion, China, 2015-2023

The rising prevalence of congenital heart defects, owing to life style factors, miscarriage, and genetic defects, are boosting the demand for interventional cardiology devices.

  • Cardiovascular Devices
  • Abbott
  • B. Braun Melsungen AG
  • C.R. Bard, Inc.
  • Cook Medical, Inc.

At least ##% of all CHDs are associated with genetic conditions.

  • Cardiovascular Devices
  • World
  • Market Size
  • Terumo Corporation
  • Toshiba Corporation

The increase in the prevalence of diabetes is common in all age groups of people; genetic factors and changes in lifestyle are some of the reasons for the increase.

  • Cardiovascular Devices
  • United States
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.

Vascular; ##(##): ##-##.

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cardinal Health, Inc.

Moreover, a rise in the incidence of genetic comorbidities is one of the factors responsible for the increase in the incidence of diseases that require thoracic surgery.

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Sorin S.p.A.

Global Peripheral Vascular Devices Market TABLE OF CONTENTS ##.

  • Cardiovascular Devices
  • Boston Scientific Corporation
  • C.R.Bard, Inc.
  • Cordis Corporation
  • Medtronic, Inc.
  • Global Percutaneous Coronary Interventions Procedures Forecast ($m), 2013-2022

India is the most significantly impacted by the disease, where genetic factors, in combination with poor diet, have contributed to the rising rate of the disease.

  • Cardiovascular Devices
  • B. Braun Melsungen AG
  • Biosensors International Group, Ltd.
  • Biotronik AG
  • Boston Scientific Corporation
  • 06.2 Market Size and Forecast
  • 11. Market Growth Drivers

Genetic and co-morbid factors are major contributors too.

  • Cardiovascular Devices
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Cordis Corporation
  • Medtronic, Inc.
  • 4.4.4 STENT GRAFTS

PERIPHERAL ANEURYSMS ARE USUALLY GENETIC.

  • Cardiovascular Devices
  • World
  • Market Size
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • 6.1 Growth Drivers

Increasing consumption of fast food, diet colas, and genetic disorder cases, have aggravated the scale of obese people globally.

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • Cordis Corporation
  • Johnson & Johnson
  • Market landscape

You can easily book an appointment with one online.

  • Cardiovascular Devices
  • United States
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Spectranetics Corp.
  • 3.3.2 RESTRAINTS AND THREATS
  • 5.2.2 PERIPHERAL STENTS

KG Woermannkehre ##, ## Berlin, Germany.

  • Cardiovascular Devices
  • World
  • Market Size
  • Abbott
  • Biosensors International Group, Ltd.
  • 4.2.2 Prostatic Stents Market, US$ Mn (2013 - 2019)

Major drivers include increasing adoption of prostatic stents worldwide, genetic susceptibility of certain ethnicity for prostate cancer and BPH (particularly African decent).

  • Cardiovascular Devices
  • World
  • Forecast
  • Boston Scientific Corporation
  • Taewoong Medical

Drivers and Their Impact Impact on Key Customer Category Public Growth in Incidence of Cardiovascular Diseases Increased Awareness Advances in Surgical Procedures Low ## ## ## ## ## High Low ## ## ## ## ## High Low High Low High ## ## ## ## ## ## ## ## ## ## Low High High Low

  • Cardiac Management
  • Cardiovascular Devices
  • Europe
  • Boston Scientific Corporation
  • Jude Medical, Inc.

Drivers and their Impact Impact on key customer category Growing population Advances in EVAR/ TEVAR technology Emergence of regional vendors Improvement healthcare infrastructure elderly Low ## ## ## ## ## High Low High ## ## ## ## ## Low High ## ## ## ## ## High in Low ## ##

  • Cardiovascular Devices
  • China
  • Cook Medical, Inc.
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • GLOBAL GERIATRIC POPULATION (60 YEARS AND ABOVE), 2015 VS. 2030

WITH AGE, GENETIC AND LIFESTYLE FACTORS LEAD TO A BUILDUP OF PLAQUE IN THE ARTERIES. ##. ##. ##. ## ACCORDING TO AN ARTICLE PUBLISHED IN THE LANCET JOURNAL IN OCTOBER 2016, THE GLOBAL PREVALENCE OF PERIPHERAL VASCULAR DISEASES WAS ##. ## MILLION IN 2005, WHICH ROSE TO ##. ##

  • Cardiovascular Devices
  • Medical Device
  • North America
  • United States
  • Medtronic, Inc.

Cardiac Resynchronization Therapy Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025 ##.

  • Cardiac Management
  • Cardiovascular Devices
  • Patient Monitoring
  • World
  • Company Financials
  • CLARET MEDICAL RAISES USD14.5 MILLION IN SERIES C FINANCING

Social risk groups did not differ on presence of genetic syndrome or single ventricle physiology.

  • Cardiovascular Devices
  • Healthcare
  • North America
  • United States
  • Market Size

" IN MANY CASES, CHILDREN BORN WITH A GENETIC CONDITION HAVE NO REPORTED FAMILY HISTORY OF THE DISEASE, " SAID CHRIS GROTTENTHALER, CEO OF TRUE HEALTH.

  • Cardiology
  • Cardiovascular Devices
  • Canada
  • North America
  • Market Size
  • NF-KB DECOY OLIGO COATED PTA BALLOON CATHETER - PRODUCT STATUS
  • ANGES MG INC PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW

The company specializes in research and development (R& D) and practical application of genetic medicine.

  • Cardiology
  • Cardiovascular Devices
  • Clinical Trial
  • Drug Discovery And Development
  • GlobalData's company

FH IS ONE OF ## GENETIC CONDITIONS BEING TARGETED IN GEISINGER S MYCODE COMMUNITY HEALTH INITIATIVE.

  • Cardiovascular Devices
  • Healthcare
  • North America
  • United States
  • Forecast

ONE UNIT REFERS TO ONE PAC.

  • Cardiovascular Devices
  • Health Services
  • Medical Device
  • North America
  • Market Size

One unit refers to one PAC.

  • Cardiology
  • Cardiovascular Devices
  • Catheter
  • France
  • Sanofi S.A.